Thyrocare Technologies Limited: September ’21 Results Update
Moneylife Digital Team 19 November 2021
Thyrocare Technologies Limited (Thyrocare) came out with a good set of numbers for Q2FY21-22, helped by one-time government contracts related to COVID tests where government also bore the cost of consumables, thus, adding to top- as well as bottom-line. This enabled the company to achieve highest-ever sales, EBITDA (earnings before interest, taxes, depreciation and amortisation) and EBITDA...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback